Literature DB >> 25408315

Predictors and outcomes of readmission for Clostridium difficile in a national sample of medicare beneficiaries.

Courtney E Collins1, M Didem Ayturk, Fred A Anderson, Heena P Santry.   

Abstract

BACKGROUND: Rates of Clostridium difficile (CD) infections are increasing. Elderly patients may be at particular risk of recurrent CD infection. Little is known about the risk for CD readmission specifically in this age group.
METHODS: A 5% random sample of Medicare data (2009-2011) was queried for patients surviving a hospitalization for CD by ICD-9 code. Demographic (age, sex, gender), clinical (Elixhauser index, gastrointestinal comorbidities), and hospitalization (length of stay, ICU admission) characteristics as well as exposure to antibiotics and interim non-CD hospitalization were compared for those with and without a readmission for CD. A multivariable survival analysis was used to determine predictors of readmission.
RESULTS: Of 7,564 patients surviving a CD hospitalization, 8.5% were readmitted with CD in a median of 25 days (interquartile range (IQR) 14-57). In multivariable survival analyses, interim non-CD hospital exposure was the strongest predictor of CD readmission (hazard ration (HR) 3.75 95%, confidence interval (CI) 3.2-4.42). Oral and intravenous/intramuscular (IV/IM) antibiotic use, Elixhauser index, and CD as the primary diagnosis also increased the risk of CD readmission. Discharge to hospice, long-term care or a skilled nursing facility decreased the odds of CD readmission.
CONCLUSION: Hospital exposure and antibiotic use put elderly patients at risk of CD readmission. Exposure to these factors should be minimized in the immediate post discharge period.

Entities:  

Mesh:

Year:  2014        PMID: 25408315      PMCID: PMC4462125          DOI: 10.1007/s11605-014-2638-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  29 in total

1.  Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection.

Authors:  Mary Y Hu; Kianoosh Katchar; Lorraine Kyne; Seema Maroo; Sanjeev Tummala; Valley Dreisbach; Hua Xu; Daniel A Leffler; Ciarán P Kelly
Journal:  Gastroenterology       Date:  2008-12-13       Impact factor: 22.682

2.  The search for effective treatment of Clostridium difficile infection.

Authors:  Herbert L DuPont
Journal:  N Engl J Med       Date:  2011-02-03       Impact factor: 91.245

Review 3.  The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2010-08       Impact factor: 3.869

Review 4.  Understanding and improving patient compliance.

Authors:  S A Eraker; J P Kirscht; M H Becker
Journal:  Ann Intern Med       Date:  1984-02       Impact factor: 25.391

5.  Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada.

Authors:  Jacques Pepin; Marie-Eve Alary; Louis Valiquette; Evelyne Raiche; Joannie Ruel; Katalin Fulop; Dominique Godin; Claude Bourassa
Journal:  Clin Infect Dis       Date:  2005-04-25       Impact factor: 9.079

6.  Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea.

Authors:  Kjetil Garborg; Bjørn Waagsbø; Asbjørn Stallemo; Jon Matre; Anders Sundøy
Journal:  Scand J Infect Dis       Date:  2010-07-22

7.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Authors:  Jacques Pépin; Louis Valiquette; Marie-Eve Alary; Philippe Villemure; Annick Pelletier; Karine Forget; Karine Pépin; Daniel Chouinard
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

Review 8.  Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.

Authors:  Stuart Johnson
Journal:  J Infect       Date:  2009-04-05       Impact factor: 6.072

9.  A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.

Authors:  K W Garey; T K Dao-Tran; Z D Jiang; M P Price; L O Gentry; H L Dupont
Journal:  J Hosp Infect       Date:  2008-08-23       Impact factor: 3.926

10.  Predictors of first recurrence of Clostridium difficile infection: implications for initial management.

Authors:  David W Eyre; A Sarah Walker; David Wyllie; Kate E Dingle; David Griffiths; John Finney; Lily O'Connor; Alison Vaughan; Derrick W Crook; Mark H Wilcox; Timothy E A Peto
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

View more
  3 in total

1.  Age and gender differences in Clostridium difficile-related hospitalization trends in Madrid (Spain) over a 12-year period.

Authors:  M D Esteban-Vasallo; S Naval Pellicer; M F Domínguez-Berjón; M Cantero Caballero; Á Asensio; G Saravia; J Astray-Mochales
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-07       Impact factor: 3.267

2.  Post-hospitalization Treatment Regimen and Readmission for C. difficile Colitis in Medicare Beneficiaries.

Authors:  Charles M Psoinos; Courtney E Collins; M Didem Ayturk; Frederick A Anderson; Heena P Santry
Journal:  World J Surg       Date:  2018-01       Impact factor: 3.352

3.  Risk Factors for Hospital Readmission for Clostridioides difficile Infection: A Statewide Retrospective Cohort Study.

Authors:  Gregorio Benitez; Fadi Shehadeh; Markos Kalligeros; Evangelia K Mylona; Quynh-Lam Tran; Ioannis M Zacharioudakis; Eleftherios Mylonakis
Journal:  Pathogens       Date:  2022-05-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.